---
title: Re-irradiation treatment regimens for patients with recurrent glioma - Evaluation
  of the optimal dose and best concurrent therapy
date: '2024-07-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39013502/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240717183322&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: In this cohort, in patients treated with concomitant BEV
  therapy RN was less frequently detected and in patients treated with concomitant
  TMZ longer PRS was observed. Based on these results, the best concomitant therapy
  and the optimal dose should be decided on a patient-by-patient ...'
disable_comments: true
---
CONCLUSION: In this cohort, in patients treated with concomitant BEV therapy RN was less frequently detected and in patients treated with concomitant TMZ longer PRS was observed. Based on these results, the best concomitant therapy and the optimal dose should be decided on a patient-by-patient ...